HEARTBURN DRUG
Sun Pharma, Cipla enter licensing agreement with Takeda to market novel gastrointestinal drug in India
Sun Pharma and Cipla have entered a licensing deal with Takeda Pharmaceutical to commercialize Vonoprazan tablets in India. This novel drug, used to treat Gastroesophageal Reflux Disease (GERD) and related acid disorders, will be marketed by Sun Pharma as Voltapraz and by Cipla under their own brands.
Sun Pharma inks pact with Takeda to introduce gastrointestinal drug in India
Sun Pharmaceutical Industries announced a licensing deal with Takeda Pharmaceutical to market Vonoprazan, a novel gastrointestinal drug, in India. The agreement allows Sun Pharma to commercialize 10 mg and 20 mg tablets of Vonoprazan, an innovative treatment for acid peptic disorders, under a non-exclusive patent license.
Don’t pop that pill daily: Doctors red-flag proton pump inhibitors used to treat acid reflux, heartburns
The reason for the popularity of PPIs among doctors and patients is not tough to gauge. With unhealthy lifestyles and dietary habits, acidity is common among Indians. While many brands of PPIs are sold almost over-the-counter, Pan, Pantop, Omez and Rablet fly off the chemist’s shelves. Doctors warn that overuse of these drugs can have a slow and debilitating impact.
GSK settles another lawsuit on heartburn drug Zantac in California
GSK settled a lawsuit in California over its heartburn drug Zantac causing cancer. Thousands of lawsuits are still pending in California and Delaware. The FDA removed Zantac from the market, resulting in a wave of lawsuits. Analysts estimate GSK's total settlement costs at around $5 billion.
Granules India gets USFDA nod for generic drug used for short-term treatment of heartburn
Granules India has received approval from the US Food & Drug Administration (USFDA) for its generic Esomeprazole Magnesium delayed-release capsules. The capsules are used for the short-term treatment of heartburn and other symptoms of gastroesophageal reflux disease. The approval is for capsules with strengths of 20 mg and 40 mg, and they are bioequivalent and therapeutically equivalent to the reference drug, Nexium.
Drugmaker GSK settles another California lawsuit on heartburn drug Zantac
GlaxoSmithKline (GSK) has announced that it will confidentially settle another lawsuit in California regarding its discontinued heartburn drug Zantac, which is alleged to have caused cancer. The settlement comes as GSK aims to end the costly litigation. The total liability related to the lawsuits is estimated to be around $5 billion.
- Go To Page 1
Prolong use of gastroesophageal reflux medications raises risk of dementia, says study
The study's findings underscore the potential risks associated with prolonged use of proton pump inhibitors and its potential link to dementia.
Long-term use of certain acid reflux drugs linked to increased risk of dementia: Study
According to new research, people who take proton pump inhibitors for four and a half years or more may have a higher risk of dementia than people who do not take these medications. This study does not establish that acid reflux medications cause dementia; rather, it demonstrates a correlation.
Marksans Pharma gets final USFDA nod for generic version of Famotidine tablets
Marksans Pharma Ltd on Friday said it has received final approval from the US health regulator for its generic version of Famotidine tablets indicated for the treatment of acid indigestion and heartburn.
Court orders jail for two Maiden Pharma execs for exporting substandard drugs to Vietnam
India suspended production at Maiden Pharmaceuticals in October last year for violations of manufacturing standards after the World Health Organization said four of its cough syrups may have killed dozens of children in Gambia. The company has denied its drugs were at fault for the deaths in Gambia and tests by an Indian government laboratory found there were no toxins in them.
Drinking coffee on an empty stomach isn't a great idea. It can lead to heartburn
However, having coffee on an empty stomach may not cause any damage to the stomach.
Dr Reddy's, Sun Pharma recall products in US for manufacturing issues
New Jersey-based Dr Reddy's Laboratories, Inc initiated the Class III recall on November 21 this year. As per USFDA, a Class III recall is initiated in a "situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences".
Anti-diabetes drugs and patented antivirals to get cheaper, NLEM notified
For the first time, patented drugs like anti-TB bedaquiline and delamanid, anti-HIV Dolutegravir and anti-hepatitis C daclatasvir are also a part of the NLEM.
Understanding US FDA inspection: How investors and management can avoid heartburn
With India playing a significant role in the global pharmaceutical sector, one may wonder about the quality control practices adopted in the country while supplying drugs to much-developed economies such as the US & UK. USFDA inspections shed some light on this.
New toxic drug impurities detected in some heart pills in US
The impurities were found in blood pressure drugs which have been recalled in Canada as well as Europe earlier this year. U.S. officials helped lead the way in the 2018 recalls of the same type of drugs tainted with the probable carcinogen N-Nitrosodimethylamine, or NDMA, though they have yet to pull any for containing the azido impurities.
Acid reflux is more worrisome than you think, limit intake of tea & peanut butter sandwiches
Diet and lifestyle changes can ward off complaints of heartburn.
World Cancer Day: Heartburn and constant use of acid reflux drugs may double the risk of stomach tumour
Difficulty in swallowing, blood in vomit and voice change are some signs to watch out for.
'Desperation science' slows the hunt for coronavirus drugs
Desperate to solve the deadly conundrum of COVID-19, the world is clamouring for fast answers and solutions from a research system not built for haste.
Dr Reddy's recalls 1,752 bottles of heartburn drug in the US
The ongoing Class III recall is on account of "Discolouration" and because the product contains brown pellets, USFDA said. As per the US health regulator, a class III recall is initiated in a situation "in which use of or exposure to a violative product is not likely to cause adverse health consequences".
Our drug Ranitidine is safe: Strides Pharma
Ranitidine is a commonly prescribed medicine for countering acidity and is on the WHO’s Model List of Essential Medicines. In India, a host of companies including GalxoSmithKline, JB Chemicals, Cadila Pharma, Zydus Cadila, Dr Reddy’s and Sun Pharmaceuticals sell over 180 versions of the drug. Strides Pharma is likely to resume drug sale, following the report.
Dr Reddy’s recalled all batches of heartburn drug from US
Ranitidine is commonly prescribed as an antacid and the NDMA impurity scandal had rocked Indian generic makers present in US who were one of the largest suppliers of the drug. After FDA’s cautionary note, several Indian cos had to recall this product.
Drug regulator steps up monitoring of ranitidine
The US FDA announced an update of testing of NDMA in ranitidine, warning manufacturers not to use a high-temperature test for NDMA as it generates high levels of the impurity.
Abdominal pain, heartburn could be subtle signs of stomach cancer; essential for patients to master food portion control
Gastric cancer develops over many years with no obvious symptoms at the start.
Dr Reddy's launches heartburn drug in US market
Dr Reddy's Laboratories said the combined market of Prilosec OTC and private label omeprazole OTC products had US retail sales of around $492 mn for the most recent 12 months ending in October 2018.
Aurobindo Pharma gets USFDA nod for heartburn drug
Aurobindo Pharma said it "has received final approval from the US Food and Drug Administration (USFDA) to manufacture Esomeprazole Magnesium Delayed-Release Capsules OTC, 20mg".
Do you pop digestive pills often? Watch out, that's a life hazard!
Always consult a doctor before popping any pills for acidity.
Suffering from heartburn? Popping drugs may lead to 'silent' kidney damage
A new study shows that people regularly taking drugs for heartburn may experience long-term damage.
Heart attack & heartburn are not the same thing, here's how you can differentiate
Heartburn and heart attacks have striking similarities in symptoms, but have absolutely nothing in common in medical terms.
Aurobindo Pharma gets US Food and Drug Administration nod for two drugs
The drug is bio-equivalent and therapeutically equivalent to the reference listed product Pepcid AC Tablets -- 10 mg and 20 mg of McNeil Consumer Pharmaceuticals.
Load More
